US 12214023
Compositions and methods for expressing factor IX
granted A61KA61K38/465A61K38/4846
Quick answer
US patent 12214023 (Compositions and methods for expressing factor IX) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/465, A61K38/4846, A61K48/005, A61P